Equities

SeaStar Medical Holding Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
ICU:NAQ

SeaStar Medical Holding Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)2.40
  • Today's Change0.00 / 0.00%
  • Shares traded37.51k
  • 1 Year change-86.59%
  • Beta-0.9880
Data delayed at least 15 minutes, as of Feb 17 2026 20:33 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

SeaStar Medical Holding Corporation is a commercial-stage medical technology company, which is focused on transforming treatments for critically ill patients facing organ failure and potential loss of life. The Company’s Selective Cytopheretic Device (SCD) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body. It has broad potential applications for patients suffering from both acute and chronic kidney disease as well as cardiovascular and other serious inflammatory diseases. Its SCD therapy is an extracorporeal synthetic membrane device designed to bind activated leukocytes (neutrophils and monocytes) when integrated into an existing continuous renal replacement therapy (CRRT) circuit in conjunction with the use of regional citrate anticoagulation (RCA).

  • Revenue in USD (TTM)881.00k
  • Net income in USD-13.67m
  • Incorporated2020
  • Employees19.00
  • Location
    SeaStar Medical Holding Corp3513 Brighton Blvd, Suite 410DENVER 80216United StatesUSA
  • Phone+1 (813) 362-6488
  • Fax+1 (302) 655-5049
  • Websitehttps://seastarmedical.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Kelyniam Global Inc-100.00bn-100.00bn7.07m0.00--9.59----------0.0146------------------------0.6993--0.3831--------------
Scientific Industries Inc8.95m-1.24m7.16m67.00--0.5743--0.7994-0.1394-0.13890.80271.040.64261.538.80133,628.40-8.91---10.06--41.46---13.87--6.34--0.00---3.59--29.09------
Dror Ortho-Design Inc0.00-3.12m7.18m3.00---------0.0033-0.00330.00-0.00240.00----0.00-405.89-214.68---759.55-------276,220.70---69.87---------61.89------
INVO Fertility Inc6.94m-27.13m7.38m28.00------1.06-602.89-644.6750.028.630.387419.5026.14247,996.40-149.96-63.14-299.48-98.9639.1760.46-387.11-276.300.1022-10.360.2530--116.2534.57-16.33--9.88--
Biotricity Inc15.08m-4.87m7.52m46.00------0.4987-0.1887-0.18870.5821-1.172.601.498.38327,858.70-77.97-229.45----79.8464.92-30.02-184.400.1389-0.1077----14.3257.6120.01------
Tenon Medical Inc3.23m-12.81m8.00m27.00--3.69--2.47-2.76-2.760.57250.55760.27631.562.96119,740.70-109.47-174.04-149.09-976.4552.4034.39-396.26-788.171.70--0.00--11.92127.6112.25------
Meihua International Medical Tech Co Ltd89.55m9.27m8.35m619.000.28520.01870.84950.093234.1234.12302.14520.790.484453.651.05144,664.905.029.695.9011.6934.3137.0210.3513.995.6689.960.06490.00-0.19494.01-6.73-6.81-56.87--
ALR Technologies SG Ltd9.49k-8.00m8.39m6.00------884.20-0.0147-0.01470.00002-0.04760.0358----1,581.67-3,015.28-12,861.64----62.49---84,283.24-406,011.30---0.8626---------42.72------
Nexalin Technology Inc156.94k-8.68m8.44m6.00--1.73--53.79-0.6345-0.63450.01090.26220.03020.300413.5926,156.67-167.17-166.16-178.46-334.5469.5176.06-5,530.09-1,178.9513.03--0.00--52.34-4.04-63.64------
SeaStar Medical Holding Corp881.00k-13.67m8.65m19.00--0.7138--9.82-16.43-16.430.68743.360.0876--6.1046,368.42-135.86---290.37--95.35---1,551.08--3.64--0.00------5.34------
AccuStem Sciences Inc0.00-1.61m8.95m2.00---------0.1163-0.11630.00-0.18110.00----0.00-192.46--------------------------26.60------
HeartSciences Inc8.67k-9.04m9.53m15.00--2.20--1,099.73-6.95-6.950.00571.360.00130.0056--578.00-131.22-145.78-202.97-316.2157.9056.93-104,225.80-42,610.782.00-10.000.1068---76.61-41.63-32.70--21.46--
Movano Inc500.00k-17.05m9.83m32.00------19.65-6.54-6.540.0883-2.040.04850.82163.5115,625.00-165.32-159.40-360.23-208.33-270.20---3,409.60-11,662.690.3451-12.462.32------18.97---9.25--
Bioelectronics Corp1.61m-289.82k9.88m9.00------6.14-0.00002-0.000020.00007-0.00066.329.2014.53---113.86-383.59----49.4351.48-18.01-143.480.0099-0.4909----94.01-5.0975.01------
BioRegenx Inc1.93m-18.93m10.00m5.00------5.19-0.0195-0.01950.002-0.00380.20833.1547.03385,874.00-204.29---341.72--78.14---980.96--0.0416-8.01-----31.40---540.38------
Data as of Feb 17 2026. Currency figures normalised to SeaStar Medical Holding Corp's reporting currency: US Dollar USD

Institutional shareholders

3.06%Per cent of shares held by top holders
HolderShares% Held
Abante Asesores Gesti�n SGIIC SAas of 31 Dec 202527.78k0.73%
The Vanguard Group, Inc.as of 31 Dec 202523.88k0.63%
Millennium Management LLCas of 30 Sep 202517.97k0.47%
Vanguard Fiduciary Trust Co.as of 31 Dec 202513.69k0.36%
Jane Street Capital LLCas of 31 Dec 202512.70k0.33%
Trinity Financial Advisors LLC (Ohio)as of 31 Dec 20257.50k0.20%
XTX Markets LLCas of 30 Sep 20254.86k0.13%
Dynamic Advisor Solutions LLCas of 31 Dec 20252.93k0.08%
TD Securities (USA) LLCas of 30 Sep 20252.50k0.07%
Goldman Sachs & Co. LLC (Private Banking)as of 31 Dec 20252.32k0.06%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.